Related Experiment Videos
Emerging resistance to carbapenems in a tertiary care hospital in north India
Ekta Gupta1, Srujana Mohanty, Seema Sood
1Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Background And Objectives:
Carbapenems are beta-lactam antibiotics, presently considered as most potent agents for treating multi-drug resistant Gram-negative bacilli infections. In India carbapenems available for use are meropenem and imipenem, introduced recently. Resistance to these has been reported in a few bacteria especially Pseudomonas spp. We therefore retrospectively evaluated the antibiotic susceptibility pattern to these agents amongst various clinical isolates in a tertiary care hospital in north India.
Methods:
In this study Gram-negative bacterial pathogens isolated from clinical samples were tested for extended spectrum beta lactamase (ESBL) production. All ESBL positive bacteria were tested for meropenem and imipenem activity pattern using NCCLS guidelines. A total of 2626 consecutively isolated Gram-negative bacteria, which tested positive for ESBL production by the double disk diffusion method, were included.
Results:
The different bacteria isolated were Pseudomonas spp. 759, Acinetobacter spp. 676, Escherichia coli 569, Klebsiella spp. 343, Enterobacter spp. 150, Citrobacter spp. 57 and Proteus spp. 72. Overall resistance to meropenem was more (22.16%) than imipenem (17.32%). Maximum resistance was seen in Pseudomonas spp. M(R) 37.6 per cent, I(R) 30 per cent. In isolates from intensive care units (ICU) resistance to carbapenems was significantly higher than non-ICU patients.
Interpretation And Conclusion:
Resistance to meropenem and imipenem was seen in various clinical isolates of Gram-negative ESBL-positive bacteria. There is a need to alarm our clinicians for judicious use of antibiotics.
Insights
Antibiotic resistance to meropenem and imipenem is increasing in Gram-negative bacteria in India. Pseudomonas spp. showed the highest resistance, with higher rates in intensive care units, necessitating judicious antibiotic use.
Area of Science:
- Clinical microbiology and infectious diseases.
- Antimicrobial resistance surveillance.
- Pharmacology of beta-lactam antibiotics.
Background:
- Carbapenems (meropenem, imipenem) are crucial for treating multi-drug resistant Gram-negative bacilli infections.
- Emerging resistance to carbapenems in India, particularly in Pseudomonas spp., poses a significant clinical challenge.
- Understanding local antibiotic susceptibility patterns is vital for effective treatment strategies.
Purpose of the Study:
- To retrospectively evaluate the antibiotic susceptibility patterns of meropenem and imipenem.
- To assess resistance trends among Gram-negative bacterial isolates in a tertiary care hospital in North India.
- To identify specific bacterial species with high carbapenem resistance.
Main Methods:
- Analysis of 2626 Gram-negative bacterial isolates from clinical samples.
- Testing for extended-spectrum beta-lactamase (ESBL) production using the double disk diffusion method.
- Determination of meropenem and imipenem susceptibility using NCCLS guidelines for ESBL-positive isolates.
Main Results:
- Overall resistance to meropenem was 22.16% and to imipenem was 17.32%.
- Pseudomonas spp. exhibited the highest resistance rates (Meropenem: 37.6%, Imipenem: 30%).
- Carbapenem resistance was significantly higher in isolates from intensive care units (ICUs) compared to non-ICU patients.
Conclusions:
- Significant resistance to meropenem and imipenem exists among Gram-negative ESBL-positive bacteria in North India.
- The findings highlight the urgent need for increased clinician awareness regarding judicious antibiotic prescribing.
- Continuous monitoring of antibiotic resistance patterns is essential to guide antimicrobial stewardship efforts.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Antibiotic Selection
Antimicrobial Effectiveness